|
|
Home | Submit Press Release | Advertise | Submit Website
(EMAILWIRE.COM, July 18, 2013 ) Boston, MA - Domain Partners, 10% Owner of Ocera Therapeutics, Inc. (Nasdaq: OCRX) bought 1,327,491 shares of Ocera Therapeutics, Inc. from the open market on 07/15/2013 according to an SEC filing reported by insidercow.com at 07/16/2013 08:13:05 PM ET. The stock was up 40.77% after the InsiderCow.com report.
Trade amount: 1,327,491 Shares
Trade type: Open Market Buy
Price Range: 6.25 - 8.97
Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=OCRX Get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.
About InsiderCow.com
InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.
About OCRX:
Ocera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class small molecule therapeutics for the treatment of gastrointestinal motility disorders in both the acute and chronic settings. The company two clinical stage product candidates ulimorelin, which is in Phase 3, and TZP-102, which entered Phase 2b are being evaluated for the treatment of predominantly upper GI motility disorders.
Disclosure: Insidercow.com is not a registered investment adviser or broker/dealer. Insidercow.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable.
InsiderCow
Kevin Leng
781-526-8657
support@insidercow.com 
Source: EmailWire.com
|
|
